BR112013032095A8 - Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas - Google Patents

Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas

Info

Publication number
BR112013032095A8
BR112013032095A8 BR112013032095A BR112013032095A BR112013032095A8 BR 112013032095 A8 BR112013032095 A8 BR 112013032095A8 BR 112013032095 A BR112013032095 A BR 112013032095A BR 112013032095 A BR112013032095 A BR 112013032095A BR 112013032095 A8 BR112013032095 A8 BR 112013032095A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical
core
coating
coating composition
composition suitable
Prior art date
Application number
BR112013032095A
Other languages
English (en)
Other versions
BR112013032095A2 (pt
Inventor
Hermes Florian
Hendrik Schattka Jan
Meier Christian
Nollenberger Kathrin
Leubert René
Assmus Manfred
Dassinger Thomas
Riermeier Thomas
Original Assignee
Evonik Roehm Gmbh
Roehm Gmbh
Evonik Degussa Gmbh
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh, Roehm Gmbh, Evonik Degussa Gmbh, Evonik Operations Gmbh filed Critical Evonik Roehm Gmbh
Publication of BR112013032095A2 publication Critical patent/BR112013032095A2/pt
Publication of BR112013032095A8 publication Critical patent/BR112013032095A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/12Polymerisation in non-solvents
    • C08F2/16Aqueous medium
    • C08F2/22Emulsion polymerisation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/16Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06Polymerisation of acrylate or methacrylate esters on to polymers thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

COMPOSIÇÃO DE REVESTIMENTO ADEQUADA PARA FORMAS DE DOSAGEM FARMACÊUTICAS OU NUTRACÊUTICAS. A presente invenção refere-se a uma composição de revestimento adequada para o revestimento de uma forma de dosagem farmacêutica ou nutracêutica, que compreende um núcleo que compreende um ou mais princípios ativos farmacêuticos ou nutracêuticos, em que a composição de revestimento é composta por, pelo menos, 20 % em peso de uma composição de polímero do núcleo/revestimento entérico derivado de um processo de polimerização em emulsão, em que tanto o núcleo da composição de polímero do núcleo/revestimento é formado por meio de um polímero ou copolímero insolúvel em água, não reticulado e o revestimento da composição de polímero do núcleo/revestimento é formado por meio de um polímero ou copolímero ou aniônico vice-versa.
BR112013032095A 2011-06-17 2011-06-17 Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas BR112013032095A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/060094 WO2012171575A1 (en) 2011-06-17 2011-06-17 Coating composition suitable for pharmaceutical or nutraceutical dosage forms

Publications (2)

Publication Number Publication Date
BR112013032095A2 BR112013032095A2 (pt) 2016-12-13
BR112013032095A8 true BR112013032095A8 (pt) 2022-07-05

Family

ID=44627582

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013032095A BR112013032095A8 (pt) 2011-06-17 2011-06-17 Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas

Country Status (17)

Country Link
US (1) US9844511B2 (pt)
EP (1) EP2720682B1 (pt)
JP (1) JP5847303B2 (pt)
KR (1) KR101799624B1 (pt)
CN (1) CN103608001B (pt)
AU (1) AU2011370762A1 (pt)
BR (1) BR112013032095A8 (pt)
CA (1) CA2839689C (pt)
ES (1) ES2616006T3 (pt)
HK (1) HK1191572A1 (pt)
HU (1) HUE033111T2 (pt)
IL (1) IL229166B (pt)
MX (1) MX353427B (pt)
PL (1) PL2720682T3 (pt)
RU (1) RU2606588C2 (pt)
SI (1) SI2720682T1 (pt)
WO (1) WO2012171575A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2649806C2 (ru) 2011-06-17 2018-04-04 Эвоник Рем ГмбХ Желудочно-резистентная фармацевтическая или нутрицевтическая композиция с устойчивостью к воздействию этанола
ES2786312T3 (es) * 2014-11-26 2020-10-09 Evonik Operations Gmbh Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol
US11980692B2 (en) 2017-11-17 2024-05-14 Evonik Operations Gmbh Process for preparing a coated hard shell capsule
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
KR20210099064A (ko) 2018-12-05 2021-08-11 에보니크 오퍼레이션즈 게엠베하 중합체성 입자의 제조 방법
KR20210139263A (ko) 2019-03-14 2021-11-22 에보닉 오퍼레이션스 게엠베하 코어-쉘 중합체 및 셀룰로오스를 포함하는 캡슐 쉘
CA3134989A1 (en) * 2019-04-30 2020-11-05 Ashish Guha Pellet and multi-unit pellet system (mups)
CN113950321A (zh) * 2019-06-13 2022-01-18 赢创运营有限公司 包含共聚物混合物和水溶性纤维素的粉末组合物
KR20240012433A (ko) 2021-05-25 2024-01-29 에보니크 오퍼레이션즈 게엠베하 변형 방출 코팅을 갖는 경질 쉘 캡슐
BR112023024450A2 (pt) 2021-05-25 2024-03-12 Evonik Operations Gmbh Cápsula de casca dura revestida com polímero, uso e processo de preparação da mesma
EP4176874A1 (en) 2021-11-09 2023-05-10 Evonik Operations GmbH Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system
WO2023174722A1 (en) 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5
WO2023214016A1 (en) 2022-05-06 2023-11-09 Evonik Operations Gmbh Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2135073C3 (de) 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4325856A (en) 1980-01-02 1982-04-20 The Dow Chemical Company Sequential emulsion polymerization process
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
US4677003A (en) * 1985-04-30 1987-06-30 Rohm And Haas Company Microsuspension process for preparing solvent core sequential polymer dispersion
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
WO1997003112A1 (en) * 1995-07-07 1997-01-30 Mitsubishi Rayon Co., Ltd. Powdery material and modifier for cementitious material
DE10011447A1 (de) 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
NZ528957A (en) * 2001-04-18 2005-05-27 Nostrum Pharmaceuticals Inc A novel coating for a sustained release pharmaceutical composition
ES2233876T3 (es) * 2001-12-19 2005-06-16 Astrazeneca Ab Nuevo recubrimiento de pelicula que contiene un copolimero acrilato de etilo/metacrilato de metilo y poli (acetato de vinilo).
JP3640921B2 (ja) 2001-12-28 2005-04-20 クラリアントポリマー株式会社 合成樹脂エマルジョン、それを含んでなる易水膨潤性粘着剤組成物、および合成樹脂エマルジョンの製造方法
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
MXPA04010956A (es) 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
GB2407501A (en) * 2003-11-03 2005-05-04 Ist Superiore Sanita Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell
WO2005056619A1 (en) * 2003-12-15 2005-06-23 Council Of Scientific & Industrial Research pH SENSITIVE POLYMER AND PROCESS FOR PREPARATION THEREOF
DE102004011349A1 (de) 2004-03-05 2005-09-22 Basf Ag Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten
US20060235131A1 (en) * 2005-04-15 2006-10-19 Hughes Kathleen A Process for preparing aqueous dispersions of multistage emulsion polymers
DE102006051020A1 (de) 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
PL2187875T3 (pl) 2007-09-21 2013-01-31 Evonik Roehm Gmbh Kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu dla nieopioidów z odpornością przed wpływem etanolu
CA2699227C (en) 2007-09-21 2014-12-02 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
PL2341899T3 (pl) 2008-09-24 2015-05-29 Evonik Roehm Gmbh Opioidowa kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu z odpornością na działanie etanolu
CA2738197C (en) 2008-09-24 2016-01-05 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
WO2010105672A1 (en) 2009-03-18 2010-09-23 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
CN102365083A (zh) * 2009-03-18 2012-02-29 赢创罗姆有限公司 采用包含聚合物混合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
CN102470112A (zh) * 2009-07-30 2012-05-23 赢创罗姆有限公司 包含阴离子聚合物材料和含6-22个碳原子的饱和单羧酸的盐的组合物

Also Published As

Publication number Publication date
EP2720682B1 (en) 2016-11-23
CA2839689C (en) 2018-05-01
IL229166B (en) 2018-01-31
SI2720682T1 (sl) 2017-05-31
US20140086997A1 (en) 2014-03-27
WO2012171575A1 (en) 2012-12-20
RU2014101227A (ru) 2015-09-27
CN103608001B (zh) 2015-10-14
JP5847303B2 (ja) 2016-01-20
BR112013032095A2 (pt) 2016-12-13
EP2720682A1 (en) 2014-04-23
IL229166A0 (en) 2013-12-31
KR20140041543A (ko) 2014-04-04
CN103608001A (zh) 2014-02-26
MX2013014144A (es) 2014-01-23
CA2839689A1 (en) 2012-12-20
ES2616006T3 (es) 2017-06-09
RU2606588C2 (ru) 2017-01-10
KR101799624B1 (ko) 2017-11-20
JP2014518205A (ja) 2014-07-28
US9844511B2 (en) 2017-12-19
HK1191572A1 (en) 2014-08-01
PL2720682T3 (pl) 2017-05-31
MX353427B (es) 2018-01-12
AU2011370762A1 (en) 2013-11-14
HUE033111T2 (en) 2017-11-28

Similar Documents

Publication Publication Date Title
BR112013032095A8 (pt) Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas
BR112013028453B8 (pt) Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro
BR112015002421A2 (pt) composição farmacêutica ou nutracêutica com características de liberação sustentada e com resistência contra a influência do etanol
BR112014017579A8 (pt) polímeros de silicone contendo grupos ácido sulfônico
BR112018004620A2 (pt) moduladores da expressão de kras
BR112015028605A8 (pt) uso de uma composição e uso de um imunossupressor e uma composição
BR112018011216A2 (pt) métodos para inibir a conversão de colina em trimetilamina (tma)
BR112013028399A2 (pt) artigo para o tratamento de ferimentos
BR112014026115A2 (pt) composição para tratamento dos cabelos que compreende ésteres de poliol insaturados metatetizados
BR112014026117A2 (pt) composições para higiene pessoal
BR112013033763A2 (pt) revestimentos baseados em polisiloxano para remoção de incrustação que incluem enzimas
BR112015003371B8 (pt) Composição para materiais ópticos, método para produzir um material óptico, material óptico, lente óptica, e, método para produzir uma composição para materiais ópticos
BR112015025141A2 (pt) partículas de polímero em emulsão, e, método para produção de partículas de polímero em emulsão
BR112013011428A2 (pt) composição para modificar quimicamente a região interna de um fio de cabelo
BR112014013682B8 (pt) composição para cuidado pessoal
BR112014019571A8 (pt) Composição de limpeza espumante
BR112015003894A2 (pt) materiais revestidos com bioflavonoide
BR112015002258A2 (pt) injetores de combustível com face de saída do bocal não estampada e tridimensional
BR112014017841A8 (pt) Processo para a preparação de uma composição condutora utilizando um masterbatch
BR112017010453A2 (pt) composição adesiva com mudança de cor
BR112017000044A2 (pt) método de preparação de copolímero zwitteriônico, solução de copolímero zwitteriônico, e composição de revestimento resistente a incrustações
BR112015028414A2 (pt) composição farmacêutica de micela de polímero
BR112012006955A2 (pt) agente de acabamento mate ou fosco para vernizes de uv
BR112017011750A2 (pt) processo para a produção de 1,4-butanodiol e tetraidrofurano a partir de furano
BR112018007801A2 (pt) processo para produção de glicóis.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ROEHM GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ROEHM GMBH (DE)

B25A Requested transfer of rights approved

Owner name: EVONIK DEGUSSA GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: EVONIK OPERATIONS GMBH (DE)